Key facts
- This page summarizes Jonathan Griggs's Form 4 filing for CUMBERLAND PHARMACEUTICALS INC (CPIX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 11 Jun 2021, 17:19.
Jonathan Griggs - 17 Mar 2021 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)
- Reporting relationship
- Director
- Issuer ticker
- CPIX
- Reported as of
- 17 Mar 2021
- Net transaction value
- +$3,220
- Reporting owner signature
- Jonathan Griggs by /s/ John Hamm as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Jonathan Griggs filed Form 4 for CUMBERLAND PHARMACEUTICALS INC (CPIX) on 11 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$3,220.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CPIX
transaction
Common Stock
Award
- Transaction value
- $3,220
- Shares
- +1,000
- Change %
- +7.2%
- Price
- $3.22
- Shares after
- 14,803
- Date
- 17 Mar 2021
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Jonathan Griggs is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 1 footnote
Footnote F1
Restricted stock award will vest 100% on March 17, 2022.